Company intelligence / Profile preview
THC BioMed
- Ownership
- Private
- Employees
- ~30
- Development stage
- Other
Overview
THC BioMed is a Canadian licensed producer of medical and recreational cannabis, headquartered in Kelowna, British Columbia. The company was among the first to be licensed under Health Canada's Marihuana for Medical Purposes Regulations (MMPR) and continues to operate under the Cannabis Act. THC BioMed focuses on the research, development, and cultivation of high-quality cannabis strains, offering products such as dried flower, oils, and pre-rolls. A notable aspect of their business is the "Clone Shipper" technology, designed for the safe transport of live cannabis plants. The company is publicly traded on the Canadian Securities Exchange and aims to provide consistent, pharmaceutical-grade cannabis to patients and consumers.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on THC BioMed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on THC BioMed.